Average Costs of GLP-1 Medications In November 2025, Eli Lilly and Novo Nordisk agreed to drop the prices of their injectable GLP-1 medications to $350 for a months supply, and to further reduce that cost to $245 over the next two years
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2 Diabetes 2012;61(2):364-371 doi:10.2337/db11-1019
Ufnal, M., & Nowiski, A
Nevertheless, some studies suggest that Ex-4 significantly stimulates hMSC proliferation in a dose- and time-dependent-manner, particularly at concentrations between 10 nM and 100 nM, as shown in cell viability assays 3-(4,5-dimethylthiazol-2-yl)5-(3-carboxymethoxyphenyl)2-(4-sulfophenyl)2 H-tetrazolium (MTS) and Cell Counting Kit-8 (CCK-8), as well as DNA analysis 5-ethynyl-2-deoxyuridin (EdU) incorporation and PicoGreen assay [14,15,16]
As such, suboptimal medication adherence and access can underestimate long-term ASCVD risk reduction correlates associated with GLP-1RA therapy